AQR Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
90,322
+62,029
+219% +$2.3M ﹤0.01% 2105
2025
Q4
$1.19M Buy
28,293
+1,071
+4% +$43.2K ﹤0.01% 2455
2025
Q3
$935K Sell
27,222
-27,945
-51% -$802K ﹤0.01% 2474
2025
Q2
$1.49M Sell
55,167
-140,722
-72% -$4.08M ﹤0.01% 1955
2025
Q1
$5.81M Sell
195,889
-34,410
-15% -$1.31M 0.01% 1064
2024
Q4
$9.12M Buy
230,299
+40,007
+21% +$1.51M 0.01% 851
2024
Q3
$6.48M Buy
190,292
+131,875
+226% +$3.71M 0.01% 944
2024
Q2
$1.27M Sell
58,417
-9,544
-14% -$201K ﹤0.01% 1650
2024
Q1
$1.51M Buy
67,961
+14,122
+26% +$345K ﹤0.01% 1525
2023
Q4
$1.48M Sell
53,839
-14,596
-21% -$352K ﹤0.01% 1467
2023
Q3
$1.53M Buy
68,435
+16,269
+31% +$418K ﹤0.01% 1440
2023
Q2
$1.33M Buy
52,166
+27,565
+112% +$668K ﹤0.01% 1445
2023
Q1
$549K Buy
24,601
+2,287
+10% +$55.3K ﹤0.01% 1747
2022
Q4
$530K Buy
+22,314
New +$519K ﹤0.01% 1792
2022
Q1
Sell
-16,105
Closed -$664K 2301
2021
Q4
$664K Sell
16,105
-12,075
-43% -$533K ﹤0.01% 1733
2021
Q3
$1.31M Buy
28,180
+11,763
+72% +$513K ﹤0.01% 1397
2021
Q2
$656K Sell
16,417
-1,188
-7% -$50.8K ﹤0.01% 1790
2021
Q1
$946K Buy
17,605
+259
+1% +$14.9K ﹤0.01% 1576
2020
Q4
$849K Sell
17,346
-710
-4% -$32.9K ﹤0.01% 1571
2020
Q3
$587K Sell
18,056
-31,233
-63% -$993K ﹤0.01% 1652
2020
Q2
$1.28M Sell
49,289
-102,946
-68% -$2.56M ﹤0.01% 1364
2020
Q1
$3.7M Sell
152,235
-55,986
-27% -$1.41M 0.01% 876
2019
Q4
$5.81M Sell
208,221
-138,400
-40% -$3.58M 0.01% 915
2019
Q3
$8.32M Sell
346,621
-62,068
-15% -$1.65M 0.01% 810
2019
Q2
$11.7M Buy
408,689
+173,504
+74% +$4.33M 0.01% 728
2019
Q1
$5.88M Buy
+235,185
New +$4.49M 0.01% 935

Other funds holding VCYT

AQR Capital Management's VCYT Position: Q1 2026 in Review

AQR Capital Management increased its Veracyte (VCYT) stake by 219% in Q1 2026, buying an estimated $2.3M and bringing the position to 90,322 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

AQR Capital Management first reported a position in VCYT in Q1 2019 and has held it in 26 quarters since. The position peaked at $11.7M in Q2 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • AQR Capital Management held 90,322 shares of Veracyte worth $2.91M as of Q1 2026.
  • AQR Capital Management bought 62,029 Veracyte shares in Q1 2026, an estimated $2.3M.
  • Veracyte made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2105 holding.
  • AQR Capital Management first reported a position in Veracyte in Q1 2019 and has held it in 26 quarters since.
  • AQR Capital Management's Veracyte position peaked at $11.7M in Q2 2019.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.